Recon: FDA clears Roche, Lilly Alzheimer’s blood tests; Regenxbio gene therapy trial halted by FDA again
Recon: FDA clears Roche, Lilly Alzheimer’s blood tests; Regenxbio gene therapy trial halted by FDA again RAPS
Finance, IT & News
Recon: FDA clears Roche, Lilly Alzheimer’s blood tests; Regenxbio gene therapy trial halted by FDA again RAPS
FDA approves new Alzheimer’s blood test from Roche, Eli Lilly WTHR
GC Biopharma wins approval for Hunter syndrome drug in India, Taiwan Korea Biomedical Review
Implantica’s anti-reflux device secures FDA approval to tee up J&J rivalry Medical Device Network
FDA clears blood test to aid diagnostic test for Alzheimer’s Disease Open Access Government